Alembic Pharmaceuticals has received Tentative Approval from the USFDA for Macitentan Tablets, 10 mg Alembic Pharmaceuticals Limited announced that its Abbreviated New Drug Application (ANDA) for Macitentan Tablets, 10 mg has gained provisional approval from the US Food & Drug Administration (USFDA). Endothelin receptor antagonist (ERA) Macitentan Tablets are used to halt the progression of pulmonary arterial hypertension (PAH, WHO Group I). It also reduced the number of PAH hospitalisations but due to the RLD's pending exclusivity for such usage, it may not be advised for certain other purposes. reference listed drug product (RLD) Opsumit Tablets, 10 mg (Actelion)
Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.
Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.
Start using market intelligence today and allow yourself to be in control in the API market.
Check it out today and make more informed sourcing decisions! Learn More!